Review decisions
Showing 130 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1719947956895
Product Type: Drug
Control Number: 254556
DIN(s): 02512963
Manufacturer: Beigene Switzerland GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-07-09
Decision / Authorization Date: 2022-02-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1717506584978
Product Type: Drug
Control Number: 269287
DIN(s): 02438070, 02547724
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-11-01
Decision / Authorization Date: 2024-05-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1717694387694
Product Type: Drug
Control Number: 273215
DIN(s): 02512963
Manufacturer: Beigene Switzerland GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-10
Decision / Authorization Date: 2024-02-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1718716557847
Product Type: Drug
Control Number: 273103
DIN(s): 02243005
Manufacturer: Bayer Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-07
Decision / Authorization Date: 2024-02-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1723558762833
Product Type: Drug
Control Number: 272517
DIN(s): 02532549, 02532557, 02532565, 02532573
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-16
Decision / Authorization Date: 2024-02-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722529358548
Product Type: Drug
Control Number: 273484
DIN(s): 02533979, 02533987, 02533995
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-20
Decision / Authorization Date: 2024-05-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1716577628323
Product Type: Drug
Control Number: 262892
DIN(s): 02489783, 02530031
Manufacturer: GlaxoSmithKline Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-30
Decision / Authorization Date: 2024-01-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1714053364853
Product Type: Drug
Control Number: 274993
DIN(s): 02546922
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-03
Decision / Authorization Date: 2024-04-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1713813660399
Product Type: Drug
Control Number: 259651
DIN(s): 02485648
Manufacturer: Gilead Sciences Canada Inc
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-15
Decision / Authorization Date: 2022-12-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1713542168989
Product Type: Drug
Control Number: 275053
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-05
Decision / Authorization Date: 2024-04-12